Rafferty Asset Management’s Achillion Pharmaceuticals ACHN Stock Holding History

Rafferty Asset Management’s Portfolio ACHN Stock Details ACHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-120,407	Closed	-$726K	–	889
2019 Q4	$726K	Sell	120,407 -53,183	-31%	-$308K	0.01%	618
2019 Q3	$625K	Sell	173,590 -81,382	-32%	-$314K	0.01%	630
2019 Q2	$683K	Sell	254,972 -9,221	-3%	-$27.2K	0.01%	632
2019 Q1	$782K	Buy	+264,193	New	+$649K	0.01%	592

Rafferty Asset Management's ACHN Position: Q1 2020 in Review

Rafferty Asset Management sold out of Achillion Pharmaceuticals (ACHN) in Q1 2020, closing a stake of 120,407 shares — an estimated $726K sold.

Rafferty Asset Management first reported a position in ACHN in Q1 2019 and held it in 4 quarters. The position peaked at $782K in Q1 2019. 0 funds tracked by Wall St. Rank hold ACHN as of Q1 2020.

Rafferty Asset Management reported no remaining Achillion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
Rafferty Asset Management sold 120,407 Achillion Pharmaceuticals shares in Q1 2020, an estimated $726K.
Rafferty Asset Management first reported a position in Achillion Pharmaceuticals in Q1 2019 and held it in 4 quarters.
Rafferty Asset Management's Achillion Pharmaceuticals position peaked at $782K in Q1 2019.
0 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2020.

Based on Rafferty Asset Management's 13F filing for Q1 2020, filed 15 May 2020.